Jingjing Quan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jingjing Quan has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Jie Zeng
Department of Obstetrics and Gynecology, Center for Reproductive Medicine; Guangdong Provincial Key Laboratory of Major Obstetric Disease; Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology; Guangdong-Hong Kong-Macao Greater Bay Area High Education Joint Laboratory of Maternal-Fetal Medicine; The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China
4 shared publications- Chuan-Xiang Zhou
Department of Oral Pathology, Peking University School and Hospital of Stomatology, National Center of Stomatology, National Clinical Research Center for Oral Disease, National Engineering Research Center of Oral Biomaterials and Digital Medicine Devices, Beijing 100081, China
2 shared publications - Glenn Francis
Genomics For Life Pty Ltd, 1/11 Parkview Street, Milton, 4064, QLD, Australia
2 shared publications - Jane Esther Dahlstrom
School of Medicine and Psychology, Australian National University, Acton, ACT, 0200, Australia
2 shared publications Junpan Luo
Hosiptal of Stomatology, Sun Yat-sen University, Guangzhou, Guangdong, China; Guangdong Provincial Key Laboratory of Stomatology, Sun Yat-sen University, Guangzhou, Guangdong, China; Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, Guangdong, China
2 shared publications- Newell Walter Johnson
Griffith University
2 shared publications
Latest Publications
- 10 November 2026
- Published by Wiley in International Endodontic Journal
CDKN1A Mediates Regulated Cell Death in Osteoblasts and Exacerbates Periapical Bone Destruction in Apical Periodontitis
Background: Apical periodontitis is a chronic inflammatory bone‐destructive disease driven by intracanal microbial infection and host immune–inflammatory responses. Periapical bone destruction arises not only from excessive osteoclastic resorption but also from osteoblast dysfunction and dysregulated regulated cell death (RCD). CDKN1A (p21) is a canonical cell‐cycle regulator implicated in multiple RCD programs, yet its role in osteoblast injury and apical periodontitis pathogenesis remains undefined. Methods: Single‐cell RNA sequencing (ScRNA) was used to profile osteoblast subpopulations and RCD‐related gene expression in human periapical lesions. Porphyromonas gingivalis infection models were established in MG63 and MC3T3‐E1 osteoblasts, and DIA proteomics and western blot were used to evaluate RCD‐related proteins. The effects of CDKN1A, a disease‐associated hub gene screened out in DIA proteomics, on RCD‐related proteins were further examined by western blot. Lentiviral silencing and AAV‐mediated overexpression were performed in vitro and in rat apical periodontitis models. Bone destruction, RCD activation and osteogenic capacity were assessed by micro‐CT, histomorphology and multiplex immunofluorescence. Results: ScRNA data of apical periodontitis showed that osteoblasts in apical lesions exhibited enhanced apoptosis and pyroptosis and reduced ferroptosis. Single‐bacteria P. gingivalis infection markedly upregulated CDKN1A, which promoted osteoblast apoptosis and pyroptosis while suppressing necroptosis and ferroptosis. In vivo, CDKN1A expression increased with disease progression and was negatively correlated with the osteogenic marker OPN. CDKN1A overexpression aggravated bone destruction, whereas its knockdown significantly attenuated bone loss and restored osteogenic activity. Conclusion: CDKN1A acts as a critical regulator that mediates RCD of osteoblasts, impairs osteogenesis and exacerbates periapical bone destruction in apical periodontitis. Targeting CDKN1A‐mediated RCD represents a promising therapeutic strategy to limit bone destruction and promote repair in apical periodontitis.
- 10 November 2026
- Published by Wiley in International Endodontic Journal
CDKN1A Mediates Regulated Cell Death in Osteoblasts and Exacerbates Periapical Bone Destruction in Apical Periodontitis
Background: Apical periodontitis is a chronic inflammatory bone‐destructive disease driven by intracanal microbial infection and host immune–inflammatory responses. Periapical bone destruction arises not only from excessive osteoclastic resorption but also from osteoblast dysfunction and dysregulated regulated cell death (RCD). CDKN1A (p21) is a canonical cell‐cycle regulator implicated in multiple RCD programs, yet its role in osteoblast injury and apical periodontitis pathogenesis remains undefined. Methods: Single‐cell RNA sequencing (ScRNA) was used to profile osteoblast subpopulations and RCD‐related gene expression in human periapical lesions. Porphyromonas gingivalis infection models were established in MG63 and MC3T3‐E1 osteoblasts, and DIA proteomics and western blot were used to evaluate RCD‐related proteins. The effects of CDKN1A, a disease‐associated hub gene screened out in DIA proteomics, on RCD‐related proteins were further examined by western blot. Lentiviral silencing and AAV‐mediated overexpression were performed in vitro and in rat apical periodontitis models. Bone destruction, RCD activation and osteogenic capacity were assessed by micro‐CT, histomorphology and multiplex immunofluorescence. Results: ScRNA data of apical periodontitis showed that osteoblasts in apical lesions exhibited enhanced apoptosis and pyroptosis and reduced ferroptosis. Single‐bacteria P. gingivalis infection markedly upregulated CDKN1A, which promoted osteoblast apoptosis and pyroptosis while suppressing necroptosis and ferroptosis. In vivo, CDKN1A expression increased with disease progression and was negatively correlated with the osteogenic marker OPN. CDKN1A overexpression aggravated bone destruction, whereas its knockdown significantly attenuated bone loss and restored osteogenic activity. Conclusion: CDKN1A acts as a critical regulator that mediates RCD of osteoblasts, impairs osteogenesis and exacerbates periapical bone destruction in apical periodontitis. Targeting CDKN1A‐mediated RCD represents a promising therapeutic strategy to limit bone destruction and promote repair in apical periodontitis.
- Open Access
- 26 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-15
Comprehensive single-cell transcriptome analysis of autologous platelet-rich plasma therapy on human thin endometrium
Therapeutics for thin endometrium (TE) have emerged, with autologous platelet-rich plasma (PRP) therapy gaining significant attention. In the present study, ten eligible TE patients were recruited for PRP infusion. Endometrial tissue biopsies collected before and after PRP therapy (paired samples) were subjected to single-cell RNA sequencing (scRNA-seq). Additionally, haematoxylin and eosin (HE) and immunohistochemistry (IHC) were employed to validate changes in protein markers. The results demonstrated PRP therapy increased the average endometrial thickness in these patients. Cellular trajectory reconstruction analysis using gene counts and expression (CytoTRACE) scores indicated that high-stemness cells were more enriched in proliferating stromal cells (pStr) or stromal cells (Str) in post-PRP samples, while greater stemness was observed in glandular epithelial cells (GE) and luminal epithelial cells (LE). Gene set variation analysis (GSVA) revealed significant differences in mesenchymal‒epithelial transition (MET)-related gene signature scores between paired samples. Furthermore, an increased number of macrophages, particularly M1-type macrophages, was detected in post-PRP samples. As the first study to investigate the effects of PRP therapy via transcriptomic analysis, our findings suggest PRP therapy may enhance high-stemness, stimulate MET, and boost macrophage function. These insights contribute to a better understanding of the mechanisms underlying PRP therapy and its potential in treating TE patients.
- 26 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-15
Open AccessComprehensive single-cell transcriptome analysis of autologous platelet-rich plasma therapy on human thin endometrium
Therapeutics for thin endometrium (TE) have emerged, with autologous platelet-rich plasma (PRP) therapy gaining significant attention. In the present study, ten eligible TE patients were recruited for PRP infusion. Endometrial tissue biopsies collected before and after PRP therapy (paired samples) were subjected to single-cell RNA sequencing (scRNA-seq). Additionally, haematoxylin and eosin (HE) and immunohistochemistry (IHC) were employed to validate changes in protein markers. The results demonstrated PRP therapy increased the average endometrial thickness in these patients. Cellular trajectory reconstruction analysis using gene counts and expression (CytoTRACE) scores indicated that high-stemness cells were more enriched in proliferating stromal cells (pStr) or stromal cells (Str) in post-PRP samples, while greater stemness was observed in glandular epithelial cells (GE) and luminal epithelial cells (LE). Gene set variation analysis (GSVA) revealed significant differences in mesenchymal‒epithelial transition (MET)-related gene signature scores between paired samples. Furthermore, an increased number of macrophages, particularly M1-type macrophages, was detected in post-PRP samples. As the first study to investigate the effects of PRP therapy via transcriptomic analysis, our findings suggest PRP therapy may enhance high-stemness, stimulate MET, and boost macrophage function. These insights contribute to a better understanding of the mechanisms underlying PRP therapy and its potential in treating TE patients.
- 9 September 2022
- Published by Elsevier in Experimental Cell Research
- Vol. 420 (2) , 113343
Single-cell RNA analysis of chemokine expression in heterogeneous CD14+ monocytes with lipopolysaccharide-induced bone resorption
- 9 September 2022
- Published by Elsevier in Experimental Cell Research
- Vol. 420 (2) , 113343
Single-cell RNA analysis of chemokine expression in heterogeneous CD14+ monocytes with lipopolysaccharide-induced bone resorption
- Open Access
- 21 March 2018
- Published by Spandidos Publications in Oncology Letters
- Vol. 15 (5) , 7760-7768
Mutant monocyte chemoattractant protein-1 protein (7ND) inhibits osteoclast differentiation and reduces oral squamous carcinoma cell bone invasion
The seven‑amino acid truncated (7ND) protein is an N‑terminal deletion mutant of monocyte chemoattractant protein‑1 (MCP‑1) and it functions as a dominant‑negative inhibitor. 7ND and wild‑type MCP‑1 form a heterodimer, which binds to MCP‑1 receptors and inhibits monocyte chemotaxis. In the present study, the 7ND protein was cloned, expressed and purified. An MTT assay revealed that the proliferation of oral squamous cell carcinoma (OSCC) SCC25 cells was not affected following 3 days of treatment with synthetic 7ND protein. Serial dilutions of the 7ND protein were tested for monocyte migration and osteoclast differentiation, and tartrate‑resistant acid phosphatase staining demonstrated that significantly fewer osteoclasts were differentiated from cluster of differentiation 14+ (CD14+) monocytes using magnetic activated cell sorting. Immunofluorescence confirmed these results and significantly less F‑actin staining was observed in 7ND‑treated osteoclasts. Furthermore, bone invasion was examined by subcutaneously injecting SCC25 cells into the area overlaying the calvariae of nude mice. The results demonstrated that the average tumor volume of SCC25 cells with 7ND protein was similar to the average volume of tumors formed by untreated SCC25 cells. Flow cytometric analysis suggested that the CD14+ subpopulation in the bone marrow of 7ND‑treated mice was reduced compared with that of untreated mice. Micro‑computed tomography imaging revealed significantly less bone resorption in the calvariae injected with SCC25 cells plus the 7ND protein. Taken together, the results of the present study demonstrated the potential therapeutic value of the 7ND protein. The 7ND MCP‑1 variant not only functions in vitro to inhibit osteoclast differentiation, but also reduces the progression of bone invasion by OSCC cells in vivo.
- 21 March 2018
- Published by Spandidos Publications in Oncology Letters
- Vol. 15 (5) , 7760-7768
Open AccessMutant monocyte chemoattractant protein-1 protein (7ND) inhibits osteoclast differentiation and reduces oral squamous carcinoma cell bone invasion
The seven‑amino acid truncated (7ND) protein is an N‑terminal deletion mutant of monocyte chemoattractant protein‑1 (MCP‑1) and it functions as a dominant‑negative inhibitor. 7ND and wild‑type MCP‑1 form a heterodimer, which binds to MCP‑1 receptors and inhibits monocyte chemotaxis. In the present study, the 7ND protein was cloned, expressed and purified. An MTT assay revealed that the proliferation of oral squamous cell carcinoma (OSCC) SCC25 cells was not affected following 3 days of treatment with synthetic 7ND protein. Serial dilutions of the 7ND protein were tested for monocyte migration and osteoclast differentiation, and tartrate‑resistant acid phosphatase staining demonstrated that significantly fewer osteoclasts were differentiated from cluster of differentiation 14+ (CD14+) monocytes using magnetic activated cell sorting. Immunofluorescence confirmed these results and significantly less F‑actin staining was observed in 7ND‑treated osteoclasts. Furthermore, bone invasion was examined by subcutaneously injecting SCC25 cells into the area overlaying the calvariae of nude mice. The results demonstrated that the average tumor volume of SCC25 cells with 7ND protein was similar to the average volume of tumors formed by untreated SCC25 cells. Flow cytometric analysis suggested that the CD14+ subpopulation in the bone marrow of 7ND‑treated mice was reduced compared with that of untreated mice. Micro‑computed tomography imaging revealed significantly less bone resorption in the calvariae injected with SCC25 cells plus the 7ND protein. Taken together, the results of the present study demonstrated the potential therapeutic value of the 7ND protein. The 7ND MCP‑1 variant not only functions in vitro to inhibit osteoclast differentiation, but also reduces the progression of bone invasion by OSCC cells in vivo.
- Open Access
- 19 December 2017
- Published by Spandidos Publications in Oncology Reports
- Vol. 39 (3) , 1043-1051
Characterization of different osteoclast phenotypes in the progression of bone invasion by oral squamous cell carcinoma
The present study aimed to characterize different phenotypes of osteoclasts in the progression of bone invasion by oral squamous cell carcinoma (OSCC). A local bone invasion model of OSCC was established by injecting SCC25 human OSCC cells into the center of calvariae in nude mice, and all mice were found to have a typical bone resorption area. Staining for tartrate-resistant acid phosphatase (TRAP) revealed various types of giant osteoclasts in the tumour-bone interface. Bone marrow cells (BMCs) were isolated from the nude mice for primary osteoclast culture, but only a few giant osteoclasts were generated. Additionally, special blood centrifuge tubes were utilized to obtain large numbers of peripheral blood mononuclear cells (PBMCs). Using magnetic activated cell sorting (MACS) and the cytokines colony-stimulating factor (CSF) and receptor activator of nuclear factor-B ligand (RANKL), we differentiated human osteoclasts from CD14(+) monocytes of PBMCs. Bone resorption was further confirmed by a bone resorption assay. Finally, Transwell inserts were used for indirect cell co-culture of SCC25 cells and CD14(+) monocytes. Expression of specific osteoclast markers was detected by real-time PCR and western blotting. After co-culture for 3 and 6 days, conditioned medium (CM) of SCC25 cells stimulated the expression of osteoclast markers, and additional osteoclasts were detected through staining of TRAP and F-actin. In the present study distinct osteoclast phenotypes were observed in the established bone invasion animal model, and were confirmed using various primary osteoclast cultures. CM of OSCC cells may promote the expression of osteoclast markers and induce the differentiation of monocytes to mature osteoclasts, which can resorb adjacent bone tissue.
- 19 December 2017
- Published by Spandidos Publications in Oncology Reports
- Vol. 39 (3) , 1043-1051
Open AccessCharacterization of different osteoclast phenotypes in the progression of bone invasion by oral squamous cell carcinoma
The present study aimed to characterize different phenotypes of osteoclasts in the progression of bone invasion by oral squamous cell carcinoma (OSCC). A local bone invasion model of OSCC was established by injecting SCC25 human OSCC cells into the center of calvariae in nude mice, and all mice were found to have a typical bone resorption area. Staining for tartrate-resistant acid phosphatase (TRAP) revealed various types of giant osteoclasts in the tumour-bone interface. Bone marrow cells (BMCs) were isolated from the nude mice for primary osteoclast culture, but only a few giant osteoclasts were generated. Additionally, special blood centrifuge tubes were utilized to obtain large numbers of peripheral blood mononuclear cells (PBMCs). Using magnetic activated cell sorting (MACS) and the cytokines colony-stimulating factor (CSF) and receptor activator of nuclear factor-B ligand (RANKL), we differentiated human osteoclasts from CD14(+) monocytes of PBMCs. Bone resorption was further confirmed by a bone resorption assay. Finally, Transwell inserts were used for indirect cell co-culture of SCC25 cells and CD14(+) monocytes. Expression of specific osteoclast markers was detected by real-time PCR and western blotting. After co-culture for 3 and 6 days, conditioned medium (CM) of SCC25 cells stimulated the expression of osteoclast markers, and additional osteoclasts were detected through staining of TRAP and F-actin. In the present study distinct osteoclast phenotypes were observed in the established bone invasion animal model, and were confirmed using various primary osteoclast cultures. CM of OSCC cells may promote the expression of osteoclast markers and induce the differentiation of monocytes to mature osteoclasts, which can resorb adjacent bone tissue.
- Open Access
- 1 February 2017
- Published by Spandidos Publications in Oncology Reports
- Vol. 38 (2) , 850-858
Utilization of E-cadherin by monocytes from tumour cells plays key roles in the progression of bone invasion by oral squamous cell carcinoma
E-cadherin (E-cad) is recently reported to be expressed in early stages of osteoclastogenesis, and blocking E-cad with neutralizing antibodies decreases osteoclast differentiation. Since our previous research demonstrates the loss of E-cad protein in the bone invasion by oral squamous cell carcinoma (OSCC), we hypothesize that E-cad may be utilized by monocytes to fuse and differentiate into osteoclasts. Two research models are used in the present study to explore our hypothesis. On one hand, we use OSCC cells of SCC25 to establish an animal model of bone invasion by OSCC, and investigate whether E-cad protein disappears in vivo; on the other hand, we use the indirect co-culture model of SCC25 and RAW 264.7 cells, with the treatment of transforming growth factor-β1 (TGF-β1), and observe whether the decreased E-cad protein is 'hijacked' in vitro. Results showed the animal model of OSCC with bone invasion was successfully established. Immunohistochemistry (IHC) found similar changes of E-cad protein, which was weakly stained by tumour cells. By using 5 ng/ml of TGF-β1, we confirmed the artificial epithelial-mesenchymal transition (EMT) of SCC25 cells, with changes of EMT marker expression and cell morphology. Real-time PCR showed E-cad mRNA decreased in SCC25 while increased in RAW 264.7 of the indirect cell co-culture model, and immunofluoresence (IF) observed the evident switch of E-cad staining from SCC25 to RAW 264.7. With the supplement of receptor activator of NF-κB ligand (RANKL), tartrate-resistant acid phosphatase (TRAP) and F-actin staining confirmed the increased number of osteoclasts. Taken together, our study found the switch of E-cad protein in the progression of bone invasion by OSCC. The loss of E-cad in tumour cells may be utilized by monocytes to differentiate into osteoclasts, thus further explaining the underlying mechanisms of bone invasion by OSCC, which may supply clues for future molecular biotherapies.
- 1 February 2017
- Published by Spandidos Publications in Oncology Reports
- Vol. 38 (2) , 850-858
Open AccessUtilization of E-cadherin by monocytes from tumour cells plays key roles in the progression of bone invasion by oral squamous cell carcinoma
E-cadherin (E-cad) is recently reported to be expressed in early stages of osteoclastogenesis, and blocking E-cad with neutralizing antibodies decreases osteoclast differentiation. Since our previous research demonstrates the loss of E-cad protein in the bone invasion by oral squamous cell carcinoma (OSCC), we hypothesize that E-cad may be utilized by monocytes to fuse and differentiate into osteoclasts. Two research models are used in the present study to explore our hypothesis. On one hand, we use OSCC cells of SCC25 to establish an animal model of bone invasion by OSCC, and investigate whether E-cad protein disappears in vivo; on the other hand, we use the indirect co-culture model of SCC25 and RAW 264.7 cells, with the treatment of transforming growth factor-β1 (TGF-β1), and observe whether the decreased E-cad protein is 'hijacked' in vitro. Results showed the animal model of OSCC with bone invasion was successfully established. Immunohistochemistry (IHC) found similar changes of E-cad protein, which was weakly stained by tumour cells. By using 5 ng/ml of TGF-β1, we confirmed the artificial epithelial-mesenchymal transition (EMT) of SCC25 cells, with changes of EMT marker expression and cell morphology. Real-time PCR showed E-cad mRNA decreased in SCC25 while increased in RAW 264.7 of the indirect cell co-culture model, and immunofluoresence (IF) observed the evident switch of E-cad staining from SCC25 to RAW 264.7. With the supplement of receptor activator of NF-κB ligand (RANKL), tartrate-resistant acid phosphatase (TRAP) and F-actin staining confirmed the increased number of osteoclasts. Taken together, our study found the switch of E-cad protein in the progression of bone invasion by OSCC. The loss of E-cad in tumour cells may be utilized by monocytes to differentiate into osteoclasts, thus further explaining the underlying mechanisms of bone invasion by OSCC, which may supply clues for future molecular biotherapies.
- Open Access
- 13 May 2016
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 14 (1) , 614
CORRIGENDUM
Due to an inability to contact various of the contributors to this study at the time of submission and a desire to publish this work, the published article did not include the full complement of authors who should have been credited on the paper. All of the existing authors have agreed that the following authors, whose names were omitted, should also have been included as co-authors: Professor Jin Gao (now at the School of Dentistry and Oral Health, Griffith University, Queensland, Australia), who was involved with project design and revisions of the manuscript; Dr Shuyu Luo (now at the School and Hospital of Stomatology, Tianjin Medical University, Tianjin, China), who was involved in project development, data collection (Figs 3 and 6) and manuscript writing; and Dr Jianming Zhang (now at the Department of Stomatology, General Hospital of Tianjin Medical University, Tianjin, China), who was involved in project development, data collection and analysis (Fig. 4) The full author list for this paper is presented below, showing the corrected order of the authors as they should have appeared on the paper. We regret the omission of the three aforementioned authors on the published article. Note that Professor Jin Gao should be considered as the co-corresponding author (with Xuefeng Xia), and Jie Zeng and Shuyu Luo contributed equally to this study. [the original article was published in the Molecular Medicine Reports 13: 174‑180, 2015; DOI: 10.3892/mmr.2015.4525] Transient transfection of macrophage migration inhibitory factor small interfering RNA disrupts the biological behavior of oral squamous carcinoma cells Jie Zeng1*, Shuyu Luo2*, Jianming Zhang3, Jingjing Quan4, Xuefeng Xia1 and Jin Gao5 1The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510150; 2School and Hospital of Stomatology, Tianjin Medical University, Tianjin 300070, 3Department of Stomatology, General Hospital of Tianjin Medical University, Tianjin 300052; 4Guanghua School of Stomatology, Hospital of Stomatology, Sun Yat-sen University and Guangdong Provincial Key Laboratory of Stomatology, Guangzhou 510080, P.R. China; 5School of Dentistry and Oral Health, Griffith University, QLD 4222, Australia Correspondence to: Professor Jin Gao, School of Dentistry and Oral Health, Griffith University, 1 Parkland Drive, QLD 4222, Australia E‑mail: jingao288@gmail.com Dr Xuefeng Xia, The Third Affiliated Hospital, Guangzhou Medical University, 63 Dunbao Road, Guangzhou, Guangdong 510150, P.R. China E‑mail: xfxiagz@126.com *Contributed equally.
- 13 May 2016
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 14 (1) , 614
Open AccessCORRIGENDUM
Due to an inability to contact various of the contributors to this study at the time of submission and a desire to publish this work, the published article did not include the full complement of authors who should have been credited on the paper. All of the existing authors have agreed that the following authors, whose names were omitted, should also have been included as co-authors: Professor Jin Gao (now at the School of Dentistry and Oral Health, Griffith University, Queensland, Australia), who was involved with project design and revisions of the manuscript; Dr Shuyu Luo (now at the School and Hospital of Stomatology, Tianjin Medical University, Tianjin, China), who was involved in project development, data collection (Figs 3 and 6) and manuscript writing; and Dr Jianming Zhang (now at the Department of Stomatology, General Hospital of Tianjin Medical University, Tianjin, China), who was involved in project development, data collection and analysis (Fig. 4) The full author list for this paper is presented below, showing the corrected order of the authors as they should have appeared on the paper. We regret the omission of the three aforementioned authors on the published article. Note that Professor Jin Gao should be considered as the co-corresponding author (with Xuefeng Xia), and Jie Zeng and Shuyu Luo contributed equally to this study. [the original article was published in the Molecular Medicine Reports 13: 174‑180, 2015; DOI: 10.3892/mmr.2015.4525] Transient transfection of macrophage migration inhibitory factor small interfering RNA disrupts the biological behavior of oral squamous carcinoma cells Jie Zeng1*, Shuyu Luo2*, Jianming Zhang3, Jingjing Quan4, Xuefeng Xia1 and Jin Gao5 1The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510150; 2School and Hospital of Stomatology, Tianjin Medical University, Tianjin 300070, 3Department of Stomatology, General Hospital of Tianjin Medical University, Tianjin 300052; 4Guanghua School of Stomatology, Hospital of Stomatology, Sun Yat-sen University and Guangdong Provincial Key Laboratory of Stomatology, Guangzhou 510080, P.R. China; 5School of Dentistry and Oral Health, Griffith University, QLD 4222, Australia Correspondence to: Professor Jin Gao, School of Dentistry and Oral Health, Griffith University, 1 Parkland Drive, QLD 4222, Australia E‑mail: jingao288@gmail.com Dr Xuefeng Xia, The Third Affiliated Hospital, Guangzhou Medical University, 63 Dunbao Road, Guangzhou, Guangdong 510150, P.R. China E‑mail: xfxiagz@126.com *Contributed equally.
- Open Access
- 6 November 2015
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 13 (1) , 174-180
Transient transfection of macrophage migration inhibitory factor small interfering RNA disrupts the biological behavior of oral squamous carcinoma cells
Macrophage migration inhibitory factor (MIF) is closely associated with tumorigenesis. The present study aimed to investigate the effects of MIF on the proliferation, migration and colony formation of oral squamous cell carcinoma (OSCC), and to quantify the protein expression levels of MIF in OSCC tissue samples. Firstly, small interfering (si) RNA was used to knock down the gene expression of MIF in Tca8113, HN5 and SCC25 OSCC cells. Secondly, proliferation, migration and colony formation of the OSCC cells were determined by MTT, transmigration and colony formation assays, respectively. Western blotting was performed to detect changes in the protein expression levels of the epithelial mesenchymal transition markers, Twist-related protein 1 (Twist1), matrix metalloproteinase (MMP)-2 and MMP-9. Finally, immunohistochemistry was used to examine the protein expression of MIF in OSCC tissue samples. The results demonstrated that siRNA against MIF significantly downregulated the expression levels of MIF in all OSCC cells, and decreased their proliferation and migration ability. Colony formation ability was also inhibited in the OSCC cells following transfection with MIF siRNA. Furthermore, western blotting demonstrated that the protein expression of Twist1 was decreased similarly to those of MIF. The protein expression of MMP-2 revealed no change, whereas that of MMP-9 decreased. The protein expression of MIF was detected in OSCC tissue samples with staining predominantly located in the cell membrane and cytoplasm. The present study demonstrated that MIF may be important in the pathogenesis and progression of OSCC, and indicated its potential therapeutic value.
- 6 November 2015
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 13 (1) , 174-180
Open AccessTransient transfection of macrophage migration inhibitory factor small interfering RNA disrupts the biological behavior of oral squamous carcinoma cells
Macrophage migration inhibitory factor (MIF) is closely associated with tumorigenesis. The present study aimed to investigate the effects of MIF on the proliferation, migration and colony formation of oral squamous cell carcinoma (OSCC), and to quantify the protein expression levels of MIF in OSCC tissue samples. Firstly, small interfering (si) RNA was used to knock down the gene expression of MIF in Tca8113, HN5 and SCC25 OSCC cells. Secondly, proliferation, migration and colony formation of the OSCC cells were determined by MTT, transmigration and colony formation assays, respectively. Western blotting was performed to detect changes in the protein expression levels of the epithelial mesenchymal transition markers, Twist-related protein 1 (Twist1), matrix metalloproteinase (MMP)-2 and MMP-9. Finally, immunohistochemistry was used to examine the protein expression of MIF in OSCC tissue samples. The results demonstrated that siRNA against MIF significantly downregulated the expression levels of MIF in all OSCC cells, and decreased their proliferation and migration ability. Colony formation ability was also inhibited in the OSCC cells following transfection with MIF siRNA. Furthermore, western blotting demonstrated that the protein expression of Twist1 was decreased similarly to those of MIF. The protein expression of MMP-2 revealed no change, whereas that of MMP-9 decreased. The protein expression of MIF was detected in OSCC tissue samples with staining predominantly located in the cell membrane and cytoplasm. The present study demonstrated that MIF may be important in the pathogenesis and progression of OSCC, and indicated its potential therapeutic value.